Registry Data ‘Reassure’ on RA Biologics’ Heart Attack Risk

There is no difference in the risk of myocardial infarction with interleukin-6 (IL-6) vs anti-tumor necrosis factor (TNF) therapy for rheumatoid arthritis.
Medscape Medical News